Skip directly to content

August 3, 2018 – Treatment Action Group, as a member of New York Counts 2020, submitted this comment to express strong opposition to the addition of a citizenship question to the 2020 U.S. Census form.

A fair and accurate census is critically important, as the federal government uses census-derived data to direct at least $800 billion annually in federal assistance to states, localities, and families.

eatan_tag_aids2018_600x113.png

26 July, 2018, Amsterdam, The Netherlands — The European African Treatment Advocates Network (EATAN), in partnership with Treatment Action Group (TAG) and other migrant-focused organizations, hosted the European African HIV & Hepatitis C Virus (HCV) Community Summit 2018. The Summit was organised as an AIDS 2018 Pre-Independent Affiliated event, taking place on 21-22 July 2018 in Amsterdam, and attended by 42 delegates from across the EU, and with 10 technical experts from the EU and North America.

The Summit aimed to launch a campaign for a European African consensus statement on migrant

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test

tb_lam_action_logos_header_739x129.png

22 July 2018, 13:00, Amsterdam, Netherlands – At the TB 2018 pre-conference held on Sunday 22 July 2018, before the International AIDS Conference, activists from around the globe called on their countries, development partners, and donors, to end the unacceptable death rates caused by tuberculosis (TB) in people living with HIV by immediately scaling up the use of TB LAM testing.

July 17, 2018 – Treatment Action Group (TAG) submitted comments to the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH) in response to a public request for information (RFI) to inform NIAID's Tuberculosis Strategic Plan on supporting TB research and development (R&D).

View or download the comment. 

This comment calls on NIAID to build on its leadership as the single largest funder of TB R&D to further deepen its commitment to catalyze the research necessary to upend the global and domestic TB epidemic.

July 16, 2018 – Treatment Action Group (TAG), NASTAD (National Alliance of State & Territorial AIDS Directors) and HIVMA (HIV Medicine Association) join together in submitting collaborative comments today in response to the Department of Health and Human Services (HHS) public request for information (RFI) on the agency’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Our comments call on Congress and the White House to boldly address a broken drug pricing system and to hold the pharmaceutical industry accountable for its role in ensuring that critical disease-preventing and

TAG_2017_ar_cove_250x347.pngAs you’ll see in our latest Annual Report, in 2017 TAG succeeded in fending off attacks on the ACA and savage budget cuts to NIH, CDC, the President’s Emergency Plan for AIDS Relief (PEPFAR), and the AIDS Drug Assistance Programs (ADAPs). These and other threats to our health, rights, and lives will continue as long as the current Administration and Congress are in office.

As two of TAG’s newest board members, we’re pleased to make a very special announcement: thanks to a generous longtime TAG supporter, all donations made in response to this message by July 31, 2018 will be matched up to

https://www.nytimes.com/2018/07/05/opinion/preventing-hiv.html

The following letter from TAG Executive Director, Mark Harrington, and Dr. Demetre Daskalakis, Deputy Commissioner of Disease Control at the New York City Department of Health and Mental Hygiene, to The New York Times was published on July 5, 2018.

Preventing HIV
July 5, 2018

To the Editor:

Re “The End of Safe Gay Sex?,” by Patrick William Kelly (Opinion Piece, nytimes.com, June 26):

Condoms work when used consistently.

hlm_header_600x100.png

TB Research Briefing for UN Missions:
THE VITAL ROLE OF RESEARCH FOR TB ELIMINATION

This briefing in New York City on June 4, 2018 provided an opportunity for discussion on the importance of investing in the full spectrum of TB research, and adopting principles to guide research to ensure efficiency and equitable access. The event featured Dr. Soumya Swaminathan, Deputy Director General for Programmes, World Health Organization, as the keynote speaker and then had three panels.

The full event can be seen here.

Watch the Introduction and Keynote Remarks.

  • Introduction: Mark Harrington,

Forging a Path to HCV Elimination: Simpler Tests and Affordable Generics
Report of the World Community Advisory Board on HCV Generics and Diagnostics
July 18–20 2017, Bangkok, Thailand

Community Advisory Boards have long played an important role in the push to expand access to medicines and in the formulation of demands for improved responses to public health challenges. HCV Community Advisory Boards have borrowed from the precedent established by HIV activists.

Pages